Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.76 |
| ▸ | CPA1 | P15085 | 7/20 | 0.66 |
| ▸ | CPA3 | P15088 | 3/20 | 0.66 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.66 |
| ▸ | CPB1 | P15086 | 1/20 | 0.66 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.66 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.65 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.65 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.65 |
| ▸ | ANPEP | P15144 | 1/20 | 0.61 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4738634 | 1.00 | CYP1A2 (0.76) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL558159 | 1.00 | CYP1A2 (0.76) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| Hydrochloric Acid SCHEMBL23699291 | 0.98 | CYP1A2 (0.73) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| Ethyl Chloride SCHEMBL1185929 | 0.91 | CYP1A2 (0.63) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL6532060 | 0.89 | CYP1A2 (0.60) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL4664822 | 0.87 | CYP1A2 (1.00) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL19532713 | 0.86 | CYP1A2 (0.61) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL6609906 | 0.86 | CYP1A2 (0.61) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7353741 | 0.86 | CYP1A2 (0.61) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL22115491 | 0.85 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112174842-B | Method for preparing (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-112209850-B | Method for preparing (S) -3-amino-2-benzyl methyl propionate | 苏州山青竹生物医药有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-213886139-U | Equipment for producing (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-213885030-U | Purification device of (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-213443914-U | Storage device of (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112209850-A | Method for preparing (S) -3-amino-2-benzyl methyl propionate | 苏州山青竹生物医药有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-112174842-A | Method for preparing (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-0446299-A4 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | — | 1992-05-13 | — | — | EP | claimed |
| EP-0446299-A1 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-09-18 | — | — | EP | claimed |
| WO-1990005785-A1 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-05-31 | — | — | WO | claimed |
| CN-109790114-B | Novel chiral ligand, metal chelate, various unnatural amino acids and synthesis method of maraviroc and key intermediate thereof | 中国科学院上海药物研究所 | 2025-03-07 | — | — | CN | disclosed |
| US-20240190930-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | UNIV NEW YORK (US) | 2024-06-13 | — | — | US | disclosed |
| US-11891422-B2 | NEMO coiled coil mimics and methods of using same | NEW YORK UNIVERSITY (US) | 2024-02-06 | — | — | US | disclosed |
| US-20240034753-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. | 2024-02-01 | — | — | US | disclosed |
| US-11753445-B2 | Therapeutic peptides | COHBAR, INC. (US) | 2023-09-12 | — | — | US | disclosed |
| EP-0792289-B1 | LOW MOLECULAR WEIGHT PEPTIDOMIMETIC GROWTH HORMONE SECRETAGOGUES | GENENTECH INC (US) | 2000-07-12 | — | — | EP | disclosed |
| US-6034216-A | Low molecular weight peptidomimetic growth hormone secretagogues | GENENTECH INC. (US) | 2000-03-07 | — | — | US | disclosed |
| EP-0446299-A4 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | — | 1992-05-13 | — | — | EP | disclosed |
| EP-0446299-A1 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-09-18 | — | — | EP | disclosed |
| WO-1990005785-A1 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891422-B2 | NEMO coiled coil mimics and methods of using same | COIL, CALCOCO2, NCAPH | CYP1A2 2802/4885CPA1 1442/4885CPA3 3159/4885 |
| US-20240190930-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | COIL, CALCOCO2, NCAPH | CYP1A2 2591/4885CPA1 1357/4885CPA3 3322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.